X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (24) 24
humans (24) 24
index medicus (23) 23
adult (18) 18
young adult (13) 13
adolescent (12) 12
cervical cancer (12) 12
papillomavirus infections - prevention & control (12) 12
cancer (11) 11
uterine cervical neoplasms - prevention & control (11) 11
middle aged (10) 10
women (10) 10
human papillomavirus (9) 9
medical and health sciences (9) 9
medicin och hälsovetenskap (9) 9
prevention (9) 9
vaccination (9) 9
papillomavirus infections (8) 8
uterine cervical neoplasms - virology (8) 8
abridged index medicus (7) 7
cervical intraepithelial neoplasia - prevention & control (7) 7
immunology (7) 7
obstetrics & gynecology (7) 7
papillomavirus infections - virology (7) 7
risk factors (7) 7
aged (6) 6
clinical medicine (6) 6
health aspects (6) 6
oncology (6) 6
research (6) 6
treatment outcome (6) 6
young-women (6) 6
cervical intraepithelial neoplasia - virology (5) 5
follow-up studies (5) 5
infection (5) 5
klinisk medicin (5) 5
papillomavirus infections - complications (5) 5
papillomavirus infections - epidemiology (5) 5
particle vaccine (5) 5
randomized controlled-trial (5) 5
singapore (5) 5
uterine cervical neoplasms - epidemiology (5) 5
uterine cervical neoplasms - pathology (5) 5
basic medicine (4) 4
cervical intraepithelial neoplasia (4) 4
diagnosis (4) 4
epidemiology (4) 4
health knowledge, attitudes, practice (4) 4
hpv (4) 4
immunization (4) 4
infectious diseases (4) 4
intraepithelial neoplasia (4) 4
lesions (4) 4
medicine, general & internal (4) 4
medicinska och farmaceutiska grundvetenskaper (4) 4
microbiology in the medical area (4) 4
mikrobiologi inom det medicinska området (4) 4
papanicolaou test (4) 4
papillomavirus vaccines - immunology (4) 4
papillomavirus vaccines - therapeutic use (4) 4
vaccines (4) 4
vaginal smears (4) 4
womens health (4) 4
allergy and immunology (3) 3
alphapapillomavirus - classification (3) 3
alphapapillomavirus - immunology (3) 3
attitudes (3) 3
cervical intraepithelial neoplasia - epidemiology (3) 3
cervical-cancer (3) 3
cervix dysplasia (3) 3
clinical-trials (3) 3
double-blind method (3) 3
follow-up (3) 3
genital diseases, female (3) 3
human papillomavirus 16 (3) 3
human papillomavirus recombinant vaccine quadrivalent, types 6, 11, 16, 18 (3) 3
infections (3) 3
infectious medicine (3) 3
infektionsmedicin (3) 3
medicine, research & experimental (3) 3
neoplasia (3) 3
obstetrics (3) 3
papillomavirus vaccines (3) 3
placebos (3) 3
pregnancy (3) 3
retrospective studies (3) 3
risk-factors (3) 3
singapore - epidemiology (3) 3
virus-like particles (3) 3
viruses (3) 3
acceptability (2) 2
adenocarcinoma (2) 2
adenocarcinoma - pathology (2) 2
adenocarcinoma - prevention & control (2) 2
alphapapillomavirus - genetics (2) 2
antibodies (2) 2
antibodies, viral - blood (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
asia (2) 2
asia - epidemiology (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2014, 2nd ed., ISBN 9789814522953
This handbook provides an evidence-based approach to common obstetrics & gynaecological problems faced by O & G clinicians and general practitioners in their... 
Handbooks, manuals, etc | Gynecology | Obstetrics
Web Resource
Journal of the National Cancer Institute, ISSN 0027-8874, 3/2010, Volume 102, Issue 5, pp. 325 - 339
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital... 
AGED 16-26 YEARS | QUADRIVALENT VACCINE | ONCOLOGY | NEUTRALIZING EPITOPES | CLINICAL-TRIALS | DOUBLE-BLIND | TYPE-18 | VIRUS-LIKE PARTICLES | PROPHYLACTIC EFFICACY | RANDOMIZED CONTROLLED-TRIAL | CERVICAL INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Tumor Virus Infections - virology | Humans | Uterine Cervical Neoplasms - epidemiology | Genital Diseases, Female - prevention & control | Sexually Transmitted Diseases - epidemiology | Alphapapillomavirus - immunology | Human papillomavirus 16 - immunology | Sexually Transmitted Diseases - prevention & control | Young Adult | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - epidemiology | Human papillomavirus 11 - immunology | Tumor Virus Infections - epidemiology | Papillomavirus Vaccines - administration & dosage | Genital Diseases, Female - virology | Papillomavirus Infections - complications | Global Health | Papanicolaou Test | Sexually Transmitted Diseases - virology | Papillomavirus Infections - epidemiology | Kaplan-Meier Estimate | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Papillomavirus Vaccines - pharmacology | Tumor Virus Infections - prevention & control | Cervical Intraepithelial Neoplasia - virology | Tumor Virus Infections - complications | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Sexual Partners | Prevention | Complications and side effects | Care and treatment | Young women | Research | Health aspects | Papillomavirus infections | Risk factors | Genital diseases, Female | Women | Studies | Human papillomavirus | Immunization | Teenagers | Vaccines | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2007, Volume 356, Issue 19, pp. 1915 - 1927
In this large, randomized, placebo-controlled trial, a quadrivalent vaccine (including human papillomavirus types 6, 11, 16 and 18) given at day 1, month 2,... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | PARTICLE VACCINE | CYTOLOGY INTERPRETATIONS | FOLLOW-UP | INFECTION | RANDOMIZED CONTROLLED-TRIAL | INTRAEPITHELIAL NEOPLASIA | YOUNG-WOMEN | SUSTAINED EFFICACY | HPV TYPES | Double-Blind Method | Follow-Up Studies | Humans | Uterine Cervical Neoplasms - epidemiology | Uterine Cervical Neoplasms - prevention & control | Treatment Outcome | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Alphapapillomavirus | DNA, Viral - blood | Human papillomavirus 16 - isolation & purification | Human papillomavirus 18 - isolation & purification | Adenocarcinoma - prevention & control | Time Factors | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Papillomavirus Vaccines - adverse effects | Adult | Female | Cervical Intraepithelial Neoplasia - epidemiology | Human papillomavirus 18 - genetics | Adenocarcinoma - epidemiology | Human papillomavirus 16 - genetics | Prevention | Cervical cancer | Disease prevention | Clinical trials | Human papillomavirus | Clinical outcomes | Index Medicus | Abridged Index Medicus | Basic Medicine | Medical and Health Sciences | Microbiology in the medical area | Mikrobiologi inom det medicinska området | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2009, Volume 199, Issue 7, pp. 926 - 935
Journal Article
BMJ, ISSN 0959-8138, 2010, Volume 341, Issue 7766, pp. 239 - 239
Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV) quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal... 
Warts | RESEARCH | Lesions | Neoplasia | Population control | Vaccination | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | PARTICLE VACCINE | EXTERNAL GENITAL WARTS | CLINICAL-TRIALS | PREVENTION | TERMINOLOGY | INFECTION | HEALTH | CANCER | LESIONS | Double-Blind Method | Humans | Uterine Cervical Neoplasms - prevention & control | Treatment Outcome | Carcinoma in Situ - prevention & control | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Young Adult | Papillomavirus Infections - prevention & control | Vaginal Neoplasms - prevention & control | Cancer Vaccines | Vulvar Neoplasms - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Adult | Female | Urogenital Neoplasms - prevention & control | Papillomavirus Vaccines | Clinical trials | Human papillomavirus | Vaccines | Womens health | Index Medicus | Abridged Index Medicus | Papillomavirus Infections: prevention & control | Basic Medicine | Condylomata Acuminata: prevention & control | Medical and Health Sciences | Medicin och hälsovetenskap | Urogenital Neoplasms: prevention & control | Mikrobiologi inom det medicinska området | Uterine Cervical Neoplasms: prevention & control | Vaginal Neoplasms: prevention & control | Carcinoma in Situ: prevention & control | Microbiology in the medical area | Cervical Intraepithelial Neoplasia: prevention & control | Medicinska och farmaceutiska grundvetenskaper | Vulvar Neoplasms: prevention & control
Journal Article
Cancer Prevention Research, ISSN 1940-6207, 10/2009, Volume 2, Issue 10, pp. 868 - 878
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2009, Volume 199, Issue 7, pp. 936 - 944
Journal Article
Vaccine, ISSN 0264-410X, 2008, Volume 26, Issue 52, pp. 6844 - 6851
Abstract The efficacy of the quadrivalent Human Papillomavirus (HPV) vaccine is thought to be mediated by humoral immunity. We evaluated the correlation... 
Allergy and Immunology | Humoral immunity | Immune memory | Human Papillomavirus | MEDICINE, RESEARCH & EXPERIMENTAL | NEUTRALIZING ANTIBODIES | CANCERS | HUMAN-PAPILLOMAVIRUS TYPE-6 | IMMUNOLOGY | INTRAEPITHELIAL NEOPLASIA | IMMUNIZATION | IMMUNOGENICITY | VLP VACCINE | VIRUS-LIKE PARTICLES | GENITAL WARTS | GRADE CERVICAL LESIONS | Human papillomavirus 18 - immunology | Follow-Up Studies | Human papillomavirus 6 - immunology | Humans | Condylomata Acuminata - epidemiology | Human papillomavirus 16 - immunology | Condylomata Acuminata - prevention & control | Papillomavirus Infections - pathology | Young Adult | Antibodies, Viral - analysis | Condylomata Acuminata - immunology | Papillomavirus Infections - immunology | Female | Immunization Schedule | Human papillomavirus 11 - immunology | Vagina - pathology | Antibodies, Viral - biosynthesis | Papanicolaou Test | Vaginal Smears | Reverse Transcriptase Polymerase Chain Reaction | Papillomavirus Infections - prevention & control | Adolescent | Antibodies, Viral - immunology | Papillomavirus Vaccines - immunology | Vulva - pathology | Evaluation | Papillomavirus infections | Vaccines | Medical research | Human papillomavirus | Immunization | Cervical cancer | Index Medicus | Basic Medicine | Medical and Health Sciences | Microbiology in the medical area | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Mikrobiologi inom det medicinska området
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 11/2007, Volume 196, Issue 10, pp. 1438 - 1446
Background. A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV) L1 virus-like-particle (VLP) vaccine has been shown to be 95%-100% effective in... 
Polymerase chain reaction | Human papillomavirus 16 | Genitalia | Vaccination | Placebos | Human papillomavirus 6 | Experimentation | Viruses | Infections | Lesions | Neoplasia | INFECTIOUS DISEASES | PARTICLE VACCINE | TYPE-16 | COHORT | RANDOMIZED CONTROLLED-TRIAL | INTRAEPITHELIAL NEOPLASIA | YOUNG-WOMEN | Prospective Studies | Humans | DNA, Viral - analysis | Antibodies, Viral - blood | Papillomaviridae - genetics | Papillomaviridae - immunology | Polymerase Chain Reaction | Adult | Female | Papillomavirus Infections - virology | Papillomavirus Vaccines - administration & dosage | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Enzyme-Linked Immunosorbent Assay | Uterine Cervical Neoplasms - prevention & control | Treatment Outcome | Injections, Intramuscular | Cervical Intraepithelial Neoplasia - virology | Sexually Transmitted Diseases, Viral - virology | Papillomavirus Infections - prevention & control | Papillomaviridae - classification | Adolescent | Sexually Transmitted Diseases, Viral - prevention & control | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Prevention | Papillomavirus infections | Genital diseases, Female | Index Medicus | Abridged Index Medicus | Infectious Medicine | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Infektionsmedicin
Journal Article
Human Vaccines, ISSN 1554-8600, 10/2009, Volume 5, Issue 10, pp. 696 - 704
Journal Article
Journal Article